NatureCell
CompanySouth Korea
NatureCell develops one asset. Mostly cell therapy acting on inflammation; based in South Korea.
- 1
- Asset
- Furthest stage
- Not known
- 0
- Trials
- 1
- Signal
Pipeline
1Autologous adipose-derived mesenchymal stem cells support cartilage repair and modulate inflammation in osteoarthritic knees.
Stage not known, Cell therapy, Inflammation
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Signals1
- Similar companies6